drugset / Trial / NCT00116545
TART - Troglitazone Atherosclerosis Regression Trial
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine if troglitazone reduces the progression of early preintrusive carotid atherosclerosis in insulin-requiring diabetes patients.
Timeline
- Start
- 1997-01
- Primary completion
- 2000-04
- Completion
- 2000-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | troglitazone | Small molecule | 400 mg | Oral |